保留 发表于 2025-3-28 17:20:54

Rheumatoid Arthritis Pathogenesis and Pathophysiology,tiopathogenesis in each individual patient is likely slightly different. In this chapter we will discuss risk factors which contribute to the onset of RA as well as the cellular and humoral mediators which contribute to the pathology observed in both the articular and extra-articular manifestations of RA.

形状 发表于 2025-3-28 21:45:04

http://reply.papertrans.cn/59/5891/589085/589085_42.png

详细目录 发表于 2025-3-28 23:43:29

http://reply.papertrans.cn/59/5891/589085/589085_43.png

婚姻生活 发表于 2025-3-29 05:05:23

Management of the Rheumatoid Arthritis Patient with Interstitial Lung Disease, safety of non-biologic disease-modifying antirheumatic drugs (nbDMARDs), biologic DMARDs, biosimilars and targeted synthetic DMARDs in RA-ILD. In addition, the potential role for additional immunosuppression in RA-ILD is reviewed as well as overarching recommendations proposed for patient assessment to guide treatment decisions and management.

破译密码 发表于 2025-3-29 09:08:31

The Non-ILD Pulmonary Manifestations of RA,pulmonary vasculitis. In addition, drug-induced lung disease and pulmonary infections are relatively common in this patient population. Appropriate management of pulmonary disease in patients with RA depends on identifying the exact nature of the pulmonary involvement and its severity as well as the underlying cause and individual patient context.

虚构的东西 发表于 2025-3-29 13:36:12

9楼

cumber 发表于 2025-3-29 17:25:11

10楼

外貌 发表于 2025-3-29 23:25:51

10楼

Coronation 发表于 2025-3-29 23:55:13

10楼

圆柱 发表于 2025-3-30 05:27:03

10楼
页: 1 2 3 4 [5]
查看完整版本: Titlebook: Lung Disease in Rheumatoid Arthritis; Aryeh Fischer,Joyce S. Lee Book 2018 Springer International Publishing AG 2018 Pulmonology.Rheumatol